{"data":{"profile":{"id":"d9c67122-d001-4363-b6e4-820130c01dd6","slug":"braidwell","displayName":"Braidwell","publicPageEnabled":true,"trackingTier":"FIRST_WAVE","isActive":true,"data":{"summary":"An investment manager focused on healthcare, life sciences, and computational biology.","strategyTags":["Healthcare","Life sciences","Computational biology"],"schemaVersion":1},"createdAt":"2026-07-18T23:28:04.697Z","updatedAt":"2026-07-21T17:30:06.695Z"},"managers":[{"id":"8c073638-a8e3-4cfc-bdd0-8b8c75b868f1","investorProfileId":"d9c67122-d001-4363-b6e4-820130c01dd6","cik":"0001920938","legalName":"BRAIDWELL LP","isActive":true,"data":{"sourceUrl":"https://data.sec.gov/submissions/CIK0001920938.json","schemaVersion":1},"firstTrackedAt":"2026-07-18T23:28:04.697Z","lastDiscoveryAt":"2026-07-21T17:30:01.310Z","createdAt":"2026-07-18T23:28:04.697Z","updatedAt":"2026-07-21T17:30:06.695Z"}],"snapshot":{"id":"1e915e90-5a2e-45d9-81b1-d45400e5c46b","managerId":"8c073638-a8e3-4cfc-bdd0-8b8c75b868f1","reportPeriod":"2024-09-30","throughFilingId":"f5402ac7-53f8-48bd-860e-9680b3ec70ad","methodologyVersion":"sec-13f-snapshot-v1","completeness":"COMPLETE","canonicalHash":"2c8e472819d9435b9de3f5e3b63038dbc3855e8ec2858e916588cc64471cf4ea","summary":{"counts":{"long":81,"puts":0,"calls":0,"mapped":0,"rawLines":81,"unmapped":81,"aiCovered":0,"positions":81,"otherSecurities":16},"values":{"disclosedLongUsd":"2322889382","putUnderlyingUsd":"0","callUnderlyingUsd":"0","informationTableUsd":"3527985574"},"coverage":{"aiPositionRatio":0,"aiLongValueRatio":0,"mappingPositionRatio":0,"mappingLongValueRatio":0},"warnings":["Form 13F is a delayed quarter-end disclosure and is not a current portfolio.","Options show reported underlying value, not premium paid, fund exposure, or manager intent.","AI sentiment is shown only for reviewed security mappings."],"concentration":{"top3":0.142906,"top5":0.22326,"top10":0.385401},"schemaVersion":1},"createdAt":"2026-07-19T00:01:11.091Z"},"filing":{"id":"f5402ac7-53f8-48bd-860e-9680b3ec70ad","managerId":"8c073638-a8e3-4cfc-bdd0-8b8c75b868f1","ingestionRunId":"3f1795fc-80a1-4822-bb8c-f84b84d4d220","accessionNumber":"0001920938-24-000006","formType":"13F-HR","reportPeriod":"2024-09-30","filedAt":"2024-11-14","acceptedAt":"2024-11-14T21:22:39.000Z","processingStatus":"VALIDATED","sourceStatus":"ACTIVE","data":{"hashes":{"raw":"c0578b02d50a5babd2b67295d07670852c2aa8d06037017a622ef4ff63dba015","canonical":"491114585bbf4a661a1774eecfa5731a7bacebbc2b33c92a61a1d9871a6dd734"},"source":{"directoryUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000192093824000006","filingDetailUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000192093824000006/0001920938-24-000006-index.html","coverDocumentUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000192093824000006/primary_doc.xml","informationTableUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000192093824000006/form13f.xml","completeSubmissionUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000192093824000006/0001920938-24-000006.txt"},"parsing":{"parserVersion":"sec-13f-v1"},"summary":{"valueUnit":"USD","entryCount":81,"reportedValue":"3527985574","normalizedValueUsd":"3527985574"},"artifacts":[{"kind":"COVER_XML","byteSize":2064,"fetchedAt":"2026-07-19T00:01:10.731Z","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000192093824000006/primary_doc.xml","contentHash":"45409e2df8be25fa0cc463d97075afd1d94fdec55916ec7f0c0ed9605866f092","contentType":"text/xml","parserVersion":"sec-13f-v1"},{"kind":"INFORMATION_TABLE_XML","byteSize":40882,"fetchedAt":"2026-07-19T00:01:10.789Z","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000192093824000006/form13f.xml","contentHash":"fa329759b782e91407df4b9fecd5ccfa0e4be6ab10b278e61d447de94e538f6e","contentType":"text/xml","parserVersion":"sec-13f-v1"},{"kind":"COMPLETE_SUBMISSION","byteSize":44197,"fetchedAt":"2026-07-19T00:01:10.912Z","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000192093824000006/0001920938-24-000006.txt","contentHash":"7a0869dc5d488c73a71b1f3b0de44bbd0fc3c89dd7865566c7872936f91157f9","contentType":"text/plain","parserVersion":"sec-13f-v1"}],"extensions":{},"reportType":"HOLDINGS","schemaVersion":1,"includesHoldings":true,"hasConfidentialOmissions":false},"firstSeenAt":"2026-07-19T00:01:10.511Z","lastSeenAt":"2026-07-21T17:30:01.271Z","createdAt":"2026-07-19T00:01:10.511Z","updatedAt":"2026-07-21T17:30:01.271Z"},"positions":[{"id":"6b8cee8b-2274-47aa-9f69-899cf5facab8","positionKey":"15f3267f-9b89-41c8-b291-383e351b53d6:LONG","positionKind":"LONG","marketValueUsd":"215984055","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"268252000"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"3.7806","shareChangeAbsolute":"0","valueChangeAbsolute":"7868222"},"security":{"id":"15f3267f-9b89-41c8-b291-383e351b53d6","cusip":"40131MAB5","issuerName":"GUARDANT HEALTH INC","classTitle":"NOTE11/1","securityType":"UNKNOWN","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"b914d82e-69a2-440e-97a0-4150027933bb","positionKey":"3c94594e-7d65-46d7-aac9-8b407c820f61:LONG","positionKind":"LONG","marketValueUsd":"145613126","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"140838000"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"1.8516","shareChangeAbsolute":"0","valueChangeAbsolute":"2647227"},"security":{"id":"3c94594e-7d65-46d7-aac9-8b407c820f61","cusip":"10806XAB8","issuerName":"BRIDGEBIO PHARMA INC","classTitle":"NOTE  2.500% 3/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"a9314209-60e8-4dc4-ad8d-b1296aba49bb","positionKey":"823ec5bc-f02d-40f3-a8e0-aaa29b2bdaec:LONG","positionKind":"LONG","marketValueUsd":"133257156","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"140834000"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"2.6697","shareChangeAbsolute":"0","valueChangeAbsolute":"3465119"},"security":{"id":"823ec5bc-f02d-40f3-a8e0-aaa29b2bdaec","cusip":"67011XAB9","issuerName":"NOVOCURE LTD","classTitle":"NOTE11/0","securityType":"UNKNOWN","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"d5a2b429-ddbe-4a67-9870-e30996e0e546","positionKey":"94e1b70a-cdf2-4a86-8f65-ddfd3a74f8d4:LONG","positionKind":"LONG","marketValueUsd":"119637114","longBookWeight":"0.05150357","sharesPrincipal":{"type":"SH","amount":"3170875"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-4.1889","valueChangePercent":"14.5059","shareChangeAbsolute":"-138632","valueChangeAbsolute":"15155978"},"security":{"id":"94e1b70a-cdf2-4a86-8f65-ddfd3a74f8d4","cusip":"156944100","issuerName":"CG ONCOLOGY INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"ddd8a73c-814f-4e4f-9c00-19467b182318","positionKey":"84fb0bc0-691b-4c28-835c-93ebd221af9c:LONG","positionKind":"LONG","marketValueUsd":"111855357","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"114206000"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"1.6256","shareChangeAbsolute":"0","valueChangeAbsolute":"1789324"},"security":{"id":"84fb0bc0-691b-4c28-835c-93ebd221af9c","cusip":"670704AJ4","issuerName":"NUVASIVE INC","classTitle":"NOTE  0.375% 3/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"60f07ce6-8691-4b2f-8cdc-5341ad18cac5","positionKey":"0bd65fc1-b8f0-4667-bf30-1532f51979dc:LONG","positionKind":"LONG","marketValueUsd":"106584629","longBookWeight":"0.04588450","sharesPrincipal":{"type":"SH","amount":"2707255"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"5.7284","valueChangePercent":"6.7589","shareChangeAbsolute":"146682","valueChangeAbsolute":"6747888"},"security":{"id":"0bd65fc1-b8f0-4667-bf30-1532f51979dc","cusip":"98420N105","issuerName":"XENON PHARMACEUTICALS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"aed867a8-880e-4425-b510-b6244982a7c3","positionKey":"987baedc-bbed-43cc-bd5d-18ddd1821cde:LONG","positionKind":"LONG","marketValueUsd":"105734398","longBookWeight":"0.04551848","sharesPrincipal":{"type":"SH","amount":"917674"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"20.9042","valueChangePercent":"1.1882","shareChangeAbsolute":"158665","valueChangeAbsolute":"1241629"},"security":{"id":"987baedc-bbed-43cc-bd5d-18ddd1821cde","cusip":"64125C109","issuerName":"NEUROCRINE BIOSCIENCES INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"86ba0516-e352-4f12-b98d-7bc9281204ae","positionKey":"3fcec05f-9ecd-4786-9c91-3d9d2709a11a:LONG","positionKind":"LONG","marketValueUsd":"96887183","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"116381000"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"6.6453","shareChangeAbsolute":"0","valueChangeAbsolute":"6037265"},"security":{"id":"3fcec05f-9ecd-4786-9c91-3d9d2709a11a","cusip":"64049MAB6","issuerName":"NEOGENOMICS INC","classTitle":"NOTE  0.250% 1/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"3d66c149-9ad9-446e-a699-61278d6106df","positionKey":"75433c3d-9e54-4db4-a1aa-943231234585:LONG","positionKind":"LONG","marketValueUsd":"96523095","longBookWeight":"0.04155303","sharesPrincipal":{"type":"SH","amount":"1643226"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-31.3044","valueChangePercent":"2.5457","shareChangeAbsolute":"-748816","valueChangeAbsolute":"2396242"},"security":{"id":"75433c3d-9e54-4db4-a1aa-943231234585","cusip":"03770N101","issuerName":"APOGEE THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"ba05c108-aa37-4aa8-ae17-74ec3596ff3e","positionKey":"e65f40dd-85cf-47cb-a4ad-fabb7c80a779:LONG","positionKind":"LONG","marketValueUsd":"90130278","longBookWeight":"0.03880093","sharesPrincipal":{"type":"SH","amount":"3125183"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"410.8177","valueChangePercent":"284.0454","shareChangeAbsolute":"2513383","valueChangeAbsolute":"66661630"},"security":{"id":"e65f40dd-85cf-47cb-a4ad-fabb7c80a779","cusip":"03753U106","issuerName":"APELLIS PHARMACEUTICALS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"2090b1a7-6acd-47d4-bbf4-7a6cdd41958a","positionKey":"c2ec59d4-1e57-4aeb-b2f0-eaf7f800cedd:LONG","positionKind":"LONG","marketValueUsd":"82465204","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"92740000"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"3.3429","valueChangePercent":"-2.5778","shareChangeAbsolute":"3000000","valueChangeAbsolute":"-2182051"},"security":{"id":"c2ec59d4-1e57-4aeb-b2f0-eaf7f800cedd","cusip":"46333XAH1","issuerName":"IRONWOOD PHARMACEUTICALS INC","classTitle":"NOTE  1.500% 6/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"df35c07d-e29e-4b43-9ca0-ea59af74679d","positionKey":"05b5df6c-3692-4c3f-8421-331f1ef204a8:LONG","positionKind":"LONG","marketValueUsd":"82271250","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"92700000"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"12.0918","valueChangePercent":"1.305","shareChangeAbsolute":"10000000","valueChangeAbsolute":"1059850"},"security":{"id":"05b5df6c-3692-4c3f-8421-331f1ef204a8","cusip":"252131AM9","issuerName":"DEXCOM INC","classTitle":"NOTE  0.375% 5/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"6bff7e9c-56a5-4bd0-922b-5cd962debed0","positionKey":"4a96d730-67e2-42e8-960b-acd08f02707e:LONG","positionKind":"LONG","marketValueUsd":"79266203","longBookWeight":"0.03412396","sharesPrincipal":{"type":"SH","amount":"311679"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"13.2525","valueChangePercent":"19.2991","shareChangeAbsolute":"36472","valueChangeAbsolute":"12822977"},"security":{"id":"4a96d730-67e2-42e8-960b-acd08f02707e","cusip":"016255101","issuerName":"ALIGN TECHNOLOGY INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"90619541-0503-474a-8a67-611a573b883e","positionKey":"2a0a898e-bb98-4739-a04e-533a142186fe:LONG","positionKind":"LONG","marketValueUsd":"76668325","longBookWeight":"0.03300558","sharesPrincipal":{"type":"SH","amount":"3342124"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"19.0228","valueChangePercent":"-5.4575","shareChangeAbsolute":"534156","valueChangeAbsolute":"-4425791"},"security":{"id":"2a0a898e-bb98-4739-a04e-533a142186fe","cusip":"40131M109","issuerName":"GUARDANT HEALTH INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"9ce16681-cef2-4da3-ac75-559d682c2fbd","positionKey":"a44112b2-ee17-4e43-8c30-539a6880f041:LONG","positionKind":"LONG","marketValueUsd":"76384550","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"63800000"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-6.1764","valueChangePercent":"2.6549","shareChangeAbsolute":"-4200000","valueChangeAbsolute":"1975550"},"security":{"id":"a44112b2-ee17-4e43-8c30-539a6880f041","cusip":"45784PAK7","issuerName":"INSULET CORP","classTitle":"NOTE  0.375% 9/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"732e8bcf-5b42-4029-8ce4-21d1d403e78a","positionKey":"b7a0ab4d-df6c-4c26-9db1-b6124ee1d833:LONG","positionKind":"LONG","marketValueUsd":"75119780","longBookWeight":"0.03233893","sharesPrincipal":{"type":"SH","amount":"1541551"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-7.676","valueChangePercent":"1.5792","shareChangeAbsolute":"-128169","valueChangeAbsolute":"1167881"},"security":{"id":"b7a0ab4d-df6c-4c26-9db1-b6124ee1d833","cusip":"52490G102","issuerName":"LEGEND BIOTECH CORP","classTitle":"SPONSORED ADS","securityType":"ADR","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"7cee44c7-41cb-4ee3-b761-52fa5a4ac1a9","positionKey":"c6f6b5ce-34a5-4b55-81fa-baddacadd0b1:LONG","positionKind":"LONG","marketValueUsd":"73248214","longBookWeight":"0.03153323","sharesPrincipal":{"type":"SH","amount":"1156977"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"4.5236","valueChangePercent":"24.8328","shareChangeAbsolute":"50072","valueChangeAbsolute":"14571180"},"security":{"id":"c6f6b5ce-34a5-4b55-81fa-baddacadd0b1","cusip":"92686J106","issuerName":"VIKING THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"32fbcdaf-99fe-4757-ac9f-46336c413765","positionKey":"1e7c716b-d0bd-410a-9ee5-39d44765bb4a:LONG","positionKind":"LONG","marketValueUsd":"72333880","longBookWeight":"0.03113961","sharesPrincipal":{"type":"SH","amount":"2894513"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"40.6261","valueChangePercent":"88.2296","shareChangeAbsolute":"836210","valueChangeAbsolute":"33905363"},"security":{"id":"1e7c716b-d0bd-410a-9ee5-39d44765bb4a","cusip":"G52694109","issuerName":"KINIKSA PHARMACEUTICALS INTL","classTitle":"ORD SHS CL A","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"3dab6f51-47a7-47f3-9da0-1b99b0abf8eb","positionKey":"f4fd6fb7-262a-4dfe-b739-4256f4ce0a6e:LONG","positionKind":"LONG","marketValueUsd":"70229075","longBookWeight":"0.03023349","sharesPrincipal":{"type":"SH","amount":"361428"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"70.0085","valueChangePercent":"83.5548","shareChangeAbsolute":"148834","valueChangeAbsolute":"31968533"},"security":{"id":"f4fd6fb7-262a-4dfe-b739-4256f4ce0a6e","cusip":"70975L107","issuerName":"PENUMBRA INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"18c36712-fbf2-4401-9bad-09bb4dd85873","positionKey":"f36d521a-9230-4704-829a-358c34ff5163:LONG","positionKind":"LONG","marketValueUsd":"70137375","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"73500000"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"-4.9315","shareChangeAbsolute":"0","valueChangeAbsolute":"-3638250"},"security":{"id":"f36d521a-9230-4704-829a-358c34ff5163","cusip":"252131AK3","issuerName":"DEXCOM INC","classTitle":"NOTE  0.250%11/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"fd9f59b2-c6f7-4aed-b951-163e624e63d4","positionKey":"e05d6245-b3ff-4f93-925e-2535a79443e1:LONG","positionKind":"LONG","marketValueUsd":"69415815","longBookWeight":"0.02988339","sharesPrincipal":{"type":"SH","amount":"8353287"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-7.4329","valueChangePercent":"7.4346","shareChangeAbsolute":"-670750","valueChangeAbsolute":"4803710"},"security":{"id":"e05d6245-b3ff-4f93-925e-2535a79443e1","cusip":"56600D107","issuerName":"MARAVAI LIFESCIENCES HLDGS I","classTitle":"COM CL A","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"6e9540ae-9617-426e-9bbf-e5bc106f1b84","positionKey":"070ddc7f-1434-41b8-8afe-56aa34dcd284:LONG","positionKind":"LONG","marketValueUsd":"67892772","longBookWeight":"0.02922772","sharesPrincipal":{"type":"SH","amount":"4873853"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"60.5404","valueChangePercent":"62.2879","shareChangeAbsolute":"1837949","valueChangeAbsolute":"26058015"},"security":{"id":"070ddc7f-1434-41b8-8afe-56aa34dcd284","cusip":"23954D109","issuerName":"DAY ONE BIOPHARMACEUTICALS I","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"0526cd7c-6140-4345-9d47-0276312db34b","positionKey":"895916fb-9c95-4e69-a296-bd2cc62fba66:LONG","positionKind":"LONG","marketValueUsd":"64403077","longBookWeight":"0.02772541","sharesPrincipal":{"type":"SH","amount":"2189836"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-12.9129","valueChangePercent":"8.9421","shareChangeAbsolute":"-324702","valueChangeAbsolute":"5286289"},"security":{"id":"895916fb-9c95-4e69-a296-bd2cc62fba66","cusip":"00773J202","issuerName":"SPYRE THERAPEUTICS INC","classTitle":"COM NEW","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"1a7456b1-96a5-4b5c-8ce3-df9bc9f8d7fd","positionKey":"07c57679-cde4-4b63-b3df-9097b47a2a2a:LONG","positionKind":"LONG","marketValueUsd":"59048948","longBookWeight":"0.02542047","sharesPrincipal":{"type":"SH","amount":"396781"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"22.6491","valueChangePercent":"44.7933","shareChangeAbsolute":"73272","valueChangeAbsolute":"18267403"},"security":{"id":"07c57679-cde4-4b63-b3df-9097b47a2a2a","cusip":"759916109","issuerName":"REPLIGEN CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"eba68ad8-8ea5-4842-b6c5-d33f798d32b9","positionKey":"ce4d1411-016f-4708-bda9-73ddac8af95b:LONG","positionKind":"LONG","marketValueUsd":"58097032","longBookWeight":"0.02501067","sharesPrincipal":{"type":"SH","amount":"782557"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"48.6741","valueChangePercent":"2.5415","shareChangeAbsolute":"256200","valueChangeAbsolute":"1439965"},"security":{"id":"ce4d1411-016f-4708-bda9-73ddac8af95b","cusip":"450056106","issuerName":"IRHYTHM HOLDINGS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"59f46180-2129-47b9-aa71-deaa57cfa271","positionKey":"a8790a3c-15be-434d-b329-6f88747ee17d:LONG","positionKind":"LONG","marketValueUsd":"53537621","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"56031000"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"9.652","shareChangeAbsolute":"0","valueChangeAbsolute":"4712601"},"security":{"id":"a8790a3c-15be-434d-b329-6f88747ee17d","cusip":"761299AB2","issuerName":"TRAVERE THERAPEUTICS INC","classTitle":"NOTE  2.500% 9/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"e0934c9e-7678-4944-8881-5dc5422dd945","positionKey":"e3dfc330-4fce-44ec-917a-88a8fbd9881b:LONG","positionKind":"LONG","marketValueUsd":"52510820","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"58217000"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"-7.1438","shareChangeAbsolute":"0","valueChangeAbsolute":"-4039924"},"security":{"id":"e3dfc330-4fce-44ec-917a-88a8fbd9881b","cusip":"02081GAB8","issuerName":"ALPHATEC HLDGS INC","classTitle":"NOTE  0.750% 8/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"95559e79-a43f-4e84-89af-758a543dbfaa","positionKey":"ea5218a3-0cdd-435c-89b0-7e6030705dc8:LONG","positionKind":"LONG","marketValueUsd":"52432146","longBookWeight":"0.02257195","sharesPrincipal":{"type":"SH","amount":"96724"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-42.055","valueChangePercent":"-26.9584","shareChangeAbsolute":"-70200","valueChangeAbsolute":"-19351851"},"security":{"id":"ea5218a3-0cdd-435c-89b0-7e6030705dc8","cusip":"04016X101","issuerName":"ARGENX SE","classTitle":"SPONSORED ADR","securityType":"ADR","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"3c8f6b6e-78b2-4ef6-a32e-ad506b508512","positionKey":"81f9e228-c173-4907-bc23-e829d4359ed4:LONG","positionKind":"LONG","marketValueUsd":"52267294","longBookWeight":"0.02250098","sharesPrincipal":{"type":"SH","amount":"1958310"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"81f9e228-c173-4907-bc23-e829d4359ed4","cusip":"28036F105","issuerName":"EDGEWISE THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"a555ec31-6d74-4355-8790-96b43d7e00c6","positionKey":"17a764c2-c589-4e70-97bc-216a1ee2995a:LONG","positionKind":"LONG","marketValueUsd":"50422167","longBookWeight":"0.02170665","sharesPrincipal":{"type":"SH","amount":"238911"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-37.0363","valueChangePercent":"-0.7063","shareChangeAbsolute":"-140532","valueChangeAbsolute":"-358690"},"security":{"id":"17a764c2-c589-4e70-97bc-216a1ee2995a","cusip":"457730109","issuerName":"INSPIRE MED SYS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"131d2db5-f838-4e0f-aad7-7e4fec9c0b77","positionKey":"d6512c87-6964-4086-bec8-0077739bc253:LONG","positionKind":"LONG","marketValueUsd":"46259256","longBookWeight":"0.01991453","sharesPrincipal":{"type":"SH","amount":"370400"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"352.2588","valueChangePercent":"257.4848","shareChangeAbsolute":"288500","valueChangeAbsolute":"33319056"},"security":{"id":"d6512c87-6964-4086-bec8-0077739bc253","cusip":"803607100","issuerName":"SAREPTA THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"3596f63c-68f9-42a1-9e1a-b7cdef06decf","positionKey":"a574bde3-483c-475d-87d0-b6b4bfcaab2d:LONG","positionKind":"LONG","marketValueUsd":"45018960","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"53594000"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-18.2943","valueChangePercent":"-13.8702","shareChangeAbsolute":"-12000000","valueChangeAbsolute":"-7249801"},"security":{"id":"a574bde3-483c-475d-87d0-b6b4bfcaab2d","cusip":"10806XAD4","issuerName":"BRIDGEBIO PHARMA INC","classTitle":"NOTE  2.250% 2/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"6c1d8557-f71d-466f-9bab-e861ba887b2a","positionKey":"9c1e8170-8764-49c2-80bc-cb7673e6af38:LONG","positionKind":"LONG","marketValueUsd":"44852951","longBookWeight":"0.01930912","sharesPrincipal":{"type":"SH","amount":"91300"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-9.1542","valueChangePercent":"0.3255","shareChangeAbsolute":"-9200","valueChangeAbsolute":"145526"},"security":{"id":"9c1e8170-8764-49c2-80bc-cb7673e6af38","cusip":"46120E602","issuerName":"INTUITIVE SURGICAL INC","classTitle":"COM NEW","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"f3a6b303-57e1-43e5-a9be-563ac83e34e6","positionKey":"1c12d225-4e4b-44ac-b9aa-dfa33fc6e852:LONG","positionKind":"LONG","marketValueUsd":"44445935","longBookWeight":"0.01913390","sharesPrincipal":{"type":"SH","amount":"3388939"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"16.9148","valueChangePercent":"9.0567","shareChangeAbsolute":"490300","valueChangeAbsolute":"3691071"},"security":{"id":"1c12d225-4e4b-44ac-b9aa-dfa33fc6e852","cusip":"G29687103","issuerName":"AVADEL PHARMACEUTICALS PLC","classTitle":"COM SHS","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"d1223ed4-16f6-4648-aa84-cc7b1caaa522","positionKey":"90a02e01-df05-4709-a335-98cb39d9092b:LONG","positionKind":"LONG","marketValueUsd":"42219072","longBookWeight":"0.01817523","sharesPrincipal":{"type":"SH","amount":"1657600"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"90a02e01-df05-4709-a335-98cb39d9092b","cusip":"055477103","issuerName":"BICARA THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"3c8136ae-b628-44c5-95f2-a3245e01beb1","positionKey":"29a7be04-6b3b-4245-aa09-af8f1d5a34ff:LONG","positionKind":"LONG","marketValueUsd":"41069427","longBookWeight":"0.01768031","sharesPrincipal":{"type":"SH","amount":"707240"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-27.9949","valueChangePercent":"-8.5047","shareChangeAbsolute":"-274969","valueChangeAbsolute":"-3817524"},"security":{"id":"29a7be04-6b3b-4245-aa09-af8f1d5a34ff","cusip":"492327101","issuerName":"KEROS THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"f4ca00fc-1167-4216-89d0-dda32709f8cb","positionKey":"3b80261d-dd47-45ed-9596-8b2610ad493f:LONG","positionKind":"LONG","marketValueUsd":"40597332","longBookWeight":"0.01747708","sharesPrincipal":{"type":"SH","amount":"311616"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-37.247","valueChangePercent":"-30.9214","shareChangeAbsolute":"-184960","valueChangeAbsolute":"-18172438"},"security":{"id":"3b80261d-dd47-45ed-9596-8b2610ad493f","cusip":"377322102","issuerName":"GLAUKOS CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"686ac1fd-04c2-4f98-80e2-0474791da7db","positionKey":"e6aea122-5703-4004-9acd-cae432b212da:LONG","positionKind":"LONG","marketValueUsd":"39009856","longBookWeight":"0.01679367","sharesPrincipal":{"type":"SH","amount":"183818"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"e6aea122-5703-4004-9acd-cae432b212da","cusip":"558868105","issuerName":"MADRIGAL PHARMACEUTICALS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"b2326345-1fd4-4872-ab4e-9e369cb6026d","positionKey":"b4fa1262-cf37-4d35-a23c-d82623383d5a:LONG","positionKind":"LONG","marketValueUsd":"34003095","longBookWeight":"0.01463827","sharesPrincipal":{"type":"SH","amount":"297568"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-63.186","valueChangePercent":"-44.2891","shareChangeAbsolute":"-510735","valueChangeAbsolute":"-27031865"},"security":{"id":"b4fa1262-cf37-4d35-a23c-d82623383d5a","cusip":"92243G108","issuerName":"VAXCYTE INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"f8d96cb1-d56c-4a31-b6c4-181be0ecfd32","positionKey":"c17c190b-d314-4f53-a637-e9a628839776:LONG","positionKind":"LONG","marketValueUsd":"33656374","longBookWeight":"0.01448901","sharesPrincipal":{"type":"SH","amount":"3070837"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"203.03","valueChangePercent":"269.0232","shareChangeAbsolute":"2057460","valueChangeAbsolute":"24535981"},"security":{"id":"c17c190b-d314-4f53-a637-e9a628839776","cusip":"76029N106","issuerName":"REPLIMUNE GROUP INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"73a7a0ef-3f94-472e-8bfc-78c6b1dfea22","positionKey":"5864043c-4b12-442c-be0b-28039646ea63:LONG","positionKind":"LONG","marketValueUsd":"31636545","longBookWeight":"0.01361947","sharesPrincipal":{"type":"SH","amount":"1284472"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"148.3367","valueChangePercent":"129.772","shareChangeAbsolute":"767242","valueChangeAbsolute":"17867882"},"security":{"id":"5864043c-4b12-442c-be0b-28039646ea63","cusip":"04335A105","issuerName":"ARVINAS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"78f8e808-42bc-4344-af34-ef22ef342a3f","positionKey":"ad617f3e-e731-4609-8a18-599a7368d09c:LONG","positionKind":"LONG","marketValueUsd":"30706823","longBookWeight":"0.01321923","sharesPrincipal":{"type":"SH","amount":"168691"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"57.3918","valueChangePercent":"56.0119","shareChangeAbsolute":"61512","valueChangeAbsolute":"11024471"},"security":{"id":"ad617f3e-e731-4609-8a18-599a7368d09c","cusip":"501147102","issuerName":"KRYSTAL BIOTECH INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"5b61e050-850a-4adc-ac5d-924984218cde","positionKey":"9eaf5462-bf8c-4e86-8f14-57c20df6bae8:LONG","positionKind":"LONG","marketValueUsd":"30031645","longBookWeight":"0.01292857","sharesPrincipal":{"type":"SH","amount":"1107770"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"-5.7371","shareChangeAbsolute":"0","valueChangeAbsolute":"-1827820"},"security":{"id":"9eaf5462-bf8c-4e86-8f14-57c20df6bae8","cusip":"68752L100","issuerName":"ORTHOPEDIATRICS CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"b064ae6a-226b-4811-934e-096e34cbaa35","positionKey":"df2c2e16-9eaf-4bfb-855e-ea9bdea36421:LONG","positionKind":"LONG","marketValueUsd":"29570405","longBookWeight":"0.01273000","sharesPrincipal":{"type":"SH","amount":"441086"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"df2c2e16-9eaf-4bfb-855e-ea9bdea36421","cusip":"252131107","issuerName":"DEXCOM INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"727b239e-97d9-4c75-a59a-c721831a2a1a","positionKey":"bd29f027-a281-4c64-b567-9f108ffdd58f:LONG","positionKind":"LONG","marketValueUsd":"29425268","longBookWeight":"0.01266752","sharesPrincipal":{"type":"SH","amount":"247750"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"bd29f027-a281-4c64-b567-9f108ffdd58f","cusip":"09075V102","issuerName":"BIONTECH SE","classTitle":"SPONSORED ADS","securityType":"ADR","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"05f7e256-2866-4265-a3e1-569c998a48dc","positionKey":"db8e186f-30ed-472d-bace-1895e854a270:LONG","positionKind":"LONG","marketValueUsd":"27622528","longBookWeight":"0.01189145","sharesPrincipal":{"type":"SH","amount":"4135109"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-0.3614","valueChangePercent":"-2.6921","shareChangeAbsolute":"-15000","valueChangeAbsolute":"-764218"},"security":{"id":"db8e186f-30ed-472d-bace-1895e854a270","cusip":"69913P105","issuerName":"PARAGON 28 INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"f4d4720e-f5fc-4573-93bf-a2645ad59359","positionKey":"ba9a1165-93ae-4276-9c2c-17b48f497ba2:LONG","positionKind":"LONG","marketValueUsd":"24775943","longBookWeight":"0.01066600","sharesPrincipal":{"type":"SH","amount":"3499427"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"16.3838","valueChangePercent":"26.3799","shareChangeAbsolute":"492628","valueChangeAbsolute":"5171614"},"security":{"id":"ba9a1165-93ae-4276-9c2c-17b48f497ba2","cusip":"75943R102","issuerName":"RELAY THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"fd2aac3a-2372-4fa1-bb05-037e96b567db","positionKey":"a6ac6f9e-77d6-43f7-9a39-de15be2c127d:LONG","positionKind":"LONG","marketValueUsd":"22468321","longBookWeight":"0.00967257","sharesPrincipal":{"type":"SH","amount":"4041065"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"84.1115","valueChangePercent":"-2.042","shareChangeAbsolute":"1846165","valueChangeAbsolute":"-468384"},"security":{"id":"a6ac6f9e-77d6-43f7-9a39-de15be2c127d","cusip":"02081G201","issuerName":"ALPHATEC HLDGS INC","classTitle":"COM NEW","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"a9eb583e-7b8f-4c8e-ba38-e94370e5e983","positionKey":"0513ff4e-de98-4ce2-94aa-81fd35d9b291:LONG","positionKind":"LONG","marketValueUsd":"19766124","longBookWeight":"0.00850928","sharesPrincipal":{"type":"SH","amount":"439638"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"47.9326","valueChangePercent":"218.3844","shareChangeAbsolute":"142450","valueChangeAbsolute":"13557867"},"security":{"id":"0513ff4e-de98-4ce2-94aa-81fd35d9b291","cusip":"415858109","issuerName":"HARROW INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"72de1e8d-c791-4e62-b14b-93a55480b34a","positionKey":"2966fd89-de0f-4490-8c96-d05fc88476bf:LONG","positionKind":"LONG","marketValueUsd":"19689136","longBookWeight":"0.00847614","sharesPrincipal":{"type":"SH","amount":"1176173"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"567.6238","valueChangePercent":"540.827","shareChangeAbsolute":"1000000","valueChangeAbsolute":"16616679"},"security":{"id":"2966fd89-de0f-4490-8c96-d05fc88476bf","cusip":"230031106","issuerName":"CULLINAN THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"13d6b2ac-3e6b-4ff9-99cc-4b9208ea1fc1","positionKey":"de2554fa-18ce-44f8-9a28-69cfbd87e47a:LONG","positionKind":"LONG","marketValueUsd":"19521212","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"18400000"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"de2554fa-18ce-44f8-9a28-69cfbd87e47a","cusip":"03209RAB9","issuerName":"AMPHASTAR PHARMACEUTICALS IN","classTitle":"NOTE  2.000% 3/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"e300e8bd-a95c-4410-b325-f39bdca5b09d","positionKey":"ef410812-44ee-4893-b066-6c24ed8d172b:LONG","positionKind":"LONG","marketValueUsd":"19494445","longBookWeight":"0.00839232","sharesPrincipal":{"type":"SH","amount":"286178"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-74.9335","valueChangePercent":"-59.5851","shareChangeAbsolute":"-855500","valueChangeAbsolute":"-28741451"},"security":{"id":"ef410812-44ee-4893-b066-6c24ed8d172b","cusip":"30063P105","issuerName":"EXACT SCIENCES CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"b9d92448-261e-41bd-a5c7-850e894807f9","positionKey":"f441a5e5-e5e3-4e68-94ae-f7d92e51efe3:LONG","positionKind":"LONG","marketValueUsd":"19485999","longBookWeight":"0.00838869","sharesPrincipal":{"type":"SH","amount":"2239770"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"36.2581","valueChangePercent":"73.3107","shareChangeAbsolute":"596000","valueChangeAbsolute":"8242612"},"security":{"id":"f441a5e5-e5e3-4e68-94ae-f7d92e51efe3","cusip":"67576A100","issuerName":"OCULAR THERAPEUTIX INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"edaaf867-68e7-4709-b826-e0125d88bdd8","positionKey":"8f1dd51a-92d8-4d9c-86d2-0b6b054213a8:LONG","positionKind":"LONG","marketValueUsd":"18798717","longBookWeight":"0.00809281","sharesPrincipal":{"type":"SH","amount":"1647565"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"8f1dd51a-92d8-4d9c-86d2-0b6b054213a8","cusip":"N44445109","issuerName":"IMMATICS N.V","classTitle":"SHS","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"ff9fbb3f-c975-4559-971f-ba4af483ca19","positionKey":"6521f3be-f431-4d0b-bb52-131e0697b2de:LONG","positionKind":"LONG","marketValueUsd":"18285516","longBookWeight":"0.00787188","sharesPrincipal":{"type":"SH","amount":"4438232"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"-36.8098","shareChangeAbsolute":"0","valueChangeAbsolute":"-10651757"},"security":{"id":"6521f3be-f431-4d0b-bb52-131e0697b2de","cusip":"46333X108","issuerName":"IRONWOOD PHARMACEUTICALS INC","classTitle":"COM CL A","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"60111eab-c3e6-4717-a32f-efb0bd693d12","positionKey":"f74682d0-beb0-4380-a337-86e4192d0538:LONG","positionKind":"LONG","marketValueUsd":"15854960","longBookWeight":"0.00682553","sharesPrincipal":{"type":"SH","amount":"189200"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"f74682d0-beb0-4380-a337-86e4192d0538","cusip":"101137107","issuerName":"BOSTON SCIENTIFIC CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"bf30d40c-98a9-4cb5-9036-1aed355fedd6","positionKey":"d7aea244-93a9-42f9-b517-35bee0f3660c:LONG","positionKind":"LONG","marketValueUsd":"13517150","longBookWeight":"0.00581911","sharesPrincipal":{"type":"SH","amount":"493687"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"34.5742","valueChangePercent":"42.3741","shareChangeAbsolute":"126836","valueChangeAbsolute":"4023046"},"security":{"id":"d7aea244-93a9-42f9-b517-35bee0f3660c","cusip":"252828108","issuerName":"DIANTHUS THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"8ee7b378-01c6-4b2f-bfa9-1be237bced63","positionKey":"734ddca7-9327-4955-9638-65042f24ea97:LONG","positionKind":"LONG","marketValueUsd":"13247093","longBookWeight":"0.00570285","sharesPrincipal":{"type":"SH","amount":"1225448"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"231.688","valueChangePercent":"70.8217","shareChangeAbsolute":"855990","valueChangeAbsolute":"5492170"},"security":{"id":"734ddca7-9327-4955-9638-65042f24ea97","cusip":"35104E100","issuerName":"4D MOLECULAR THERAPEUTICS IN","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"5d0b4aee-cda4-451a-85f2-f1e2d09fbf91","positionKey":"3ddeb8b0-59cd-4730-bf6f-39ee0c5ad0e1:LONG","positionKind":"LONG","marketValueUsd":"13185002","longBookWeight":"0.00567612","sharesPrincipal":{"type":"SH","amount":"884306"},"comparison":{"status":"INCREASED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"71.1638","valueChangePercent":"55.8029","shareChangeAbsolute":"367663","valueChangeAbsolute":"4722390"},"security":{"id":"3ddeb8b0-59cd-4730-bf6f-39ee0c5ad0e1","cusip":"15102K100","issuerName":"CELCUITY INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"7720aee1-3211-4fff-968f-af1dcbfe7abf","positionKey":"3dd2a491-fab8-4a50-92b8-86e7af07c3e4:LONG","positionKind":"LONG","marketValueUsd":"12640444","longBookWeight":"0.00544169","sharesPrincipal":{"type":"SH","amount":"515726"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"3dd2a491-fab8-4a50-92b8-86e7af07c3e4","cusip":"687604108","issuerName":"ORUKA THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"f31dd22d-0b23-43ba-a4ee-6b0eb0f2e2f3","positionKey":"b7c6a44d-f955-41d2-8d3a-043e190fed48:LONG","positionKind":"LONG","marketValueUsd":"10637500","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"11500000"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"2.6067","shareChangeAbsolute":"0","valueChangeAbsolute":"270250"},"security":{"id":"b7c6a44d-f955-41d2-8d3a-043e190fed48","cusip":"405024AB6","issuerName":"HAEMONETICS CORP MASS","classTitle":"NOTE3/0","securityType":"UNKNOWN","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"f203442d-7f55-4906-8392-30807b490abe","positionKey":"0d7a1cf5-bdc2-40c6-8af1-6006ebf03471:LONG","positionKind":"LONG","marketValueUsd":"10057422","longBookWeight":"0.00432970","sharesPrincipal":{"type":"SH","amount":"2158245"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-9.3442","valueChangePercent":"-6.948","shareChangeAbsolute":"-222459","valueChangeAbsolute":"-750974"},"security":{"id":"0d7a1cf5-bdc2-40c6-8af1-6006ebf03471","cusip":"014442107","issuerName":"ALECTOR INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"76f65081-bc5d-4543-aee2-4f80b29cdd4f","positionKey":"1448e60f-367c-4ab6-99c1-a4fe79c6247c:LONG","positionKind":"LONG","marketValueUsd":"10039592","longBookWeight":"0.00432202","sharesPrincipal":{"type":"SH","amount":"2472806"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"1448e60f-367c-4ab6-99c1-a4fe79c6247c","cusip":"G9TY5A101","issuerName":"ZURA BIO LTD","classTitle":"CLASS A ORD SHS","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"fabdd98f-bbbb-40c3-ba10-3c056c20ce7a","positionKey":"5f509522-3f6d-424c-836f-ecc62d2e6d57:LONG","positionKind":"LONG","marketValueUsd":"9891875","longBookWeight":"0.00425843","sharesPrincipal":{"type":"SH","amount":"42500"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"5f509522-3f6d-424c-836f-ecc62d2e6d57","cusip":"45784P101","issuerName":"INSULET CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"0031adf6-9072-4132-a2ae-c9891bbc68d2","positionKey":"f3a07db7-653f-48c5-89a4-52689d2b2710:LONG","positionKind":"LONG","marketValueUsd":"9496113","longBookWeight":"0.00408806","sharesPrincipal":{"type":"SH","amount":"1698768"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"-33.6104","shareChangeAbsolute":"0","valueChangeAbsolute":"-4807514"},"security":{"id":"f3a07db7-653f-48c5-89a4-52689d2b2710","cusip":"64157F103","issuerName":"NEVRO CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"56b6bf45-f9af-4025-9541-f3b23c03cc78","positionKey":"bf3cd61a-4ee6-41de-a1e5-fde8d7b0c357:LONG","positionKind":"LONG","marketValueUsd":"9468241","longBookWeight":"0.00407606","sharesPrincipal":{"type":"SH","amount":"331986"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-20.2148","valueChangePercent":"4.5233","shareChangeAbsolute":"-84114","valueChangeAbsolute":"409744"},"security":{"id":"bf3cd61a-4ee6-41de-a1e5-fde8d7b0c357","cusip":"14843C105","issuerName":"CASTLE BIOSCIENCES INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"6a80991a-1c89-4702-92a8-1d85943b9076","positionKey":"31eb2795-5afb-4dce-ba59-afe410caec27:LONG","positionKind":"LONG","marketValueUsd":"9380269","longBookWeight":"0.00403819","sharesPrincipal":{"type":"SH","amount":"466448"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"31eb2795-5afb-4dce-ba59-afe410caec27","cusip":"98401F105","issuerName":"XENCOR INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"05e12018-592d-4380-9a5a-e3a491832416","positionKey":"0ff3dc16-0941-47c2-8c19-d9176329b3a0:LONG","positionKind":"LONG","marketValueUsd":"9090873","longBookWeight":"0.00391360","sharesPrincipal":{"type":"SH","amount":"483300"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"0ff3dc16-0941-47c2-8c19-d9176329b3a0","cusip":"471871202","issuerName":"JASPER THERAPEUTICS INC","classTitle":"COM NEW","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"825ecae3-f042-4e7d-b230-4206028426ef","positionKey":"8db48588-6f0b-441a-9322-8196ce8c9c20:LONG","positionKind":"LONG","marketValueUsd":"7597264","longBookWeight":"0.00327060","sharesPrincipal":{"type":"SH","amount":"298400"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-13.6501","valueChangePercent":"-13.2069","shareChangeAbsolute":"-47171","valueChangeAbsolute":"-1156049"},"security":{"id":"8db48588-6f0b-441a-9322-8196ce8c9c20","cusip":"10806X102","issuerName":"BRIDGEBIO PHARMA INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"1ef0931d-e750-43c3-b817-7805bde489fc","positionKey":"556d22c9-983d-4d47-87bb-32d664e87c46:LONG","positionKind":"LONG","marketValueUsd":"6588144","longBookWeight":"0.00283618","sharesPrincipal":{"type":"SH","amount":"728777"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-47.2848","valueChangePercent":"-70.2902","shareChangeAbsolute":"-653704","valueChangeAbsolute":"-15586851"},"security":{"id":"556d22c9-983d-4d47-87bb-32d664e87c46","cusip":"52886X107","issuerName":"LEXEO THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"9d419c29-2186-4e7b-981e-f340038ab488","positionKey":"073a24f2-cc87-4d82-8fc2-553e340bafc1:LONG","positionKind":"LONG","marketValueUsd":"6238565","longBookWeight":"0.00268569","sharesPrincipal":{"type":"SH","amount":"752541"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"30.757","shareChangeAbsolute":"0","valueChangeAbsolute":"1467455"},"security":{"id":"073a24f2-cc87-4d82-8fc2-553e340bafc1","cusip":"745848101","issuerName":"PULMONX CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"738ad437-6b29-4655-96c2-83db1015e8de","positionKey":"042a5725-6844-407a-9456-8e052ec494d8:LONG","positionKind":"LONG","marketValueUsd":"5831559","longBookWeight":"0.00251047","sharesPrincipal":{"type":"SH","amount":"4049694"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-20.9149","valueChangePercent":"-40.6862","shareChangeAbsolute":"-1070991","valueChangeAbsolute":"-4000156"},"security":{"id":"042a5725-6844-407a-9456-8e052ec494d8","cusip":"88331L108","issuerName":"THE BEAUTY HEALTH COMPANY","classTitle":"COM CL A","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"c784808d-4e3c-4af0-945f-e5a197fe85f6","positionKey":"d064662d-c6ca-4672-adf1-60de4bbc6e06:LONG","positionKind":"LONG","marketValueUsd":"4976413","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"29000000"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"-1.095","shareChangeAbsolute":"0","valueChangeAbsolute":"-55100"},"security":{"id":"d064662d-c6ca-4672-adf1-60de4bbc6e06","cusip":"232109AG3","issuerName":"CUTERA INC","classTitle":"NOTE  4.000% 6/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"d9253e4e-2519-4f7d-a88b-55396127a725","positionKey":"fe7627a3-edab-4957-b4b3-1428643733a7:LONG","positionKind":"LONG","marketValueUsd":"4038410","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"25240000"},"comparison":{"status":"UNCHANGED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"0.0","valueChangePercent":"-19.9998","shareChangeAbsolute":"0","valueChangeAbsolute":"-1009590"},"security":{"id":"fe7627a3-edab-4957-b4b3-1428643733a7","cusip":"232109AD0","issuerName":"CUTERA INC","classTitle":"NOTE  2.250% 6/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"5701c28c-5026-47ad-a4e3-28d66fa893e6","positionKey":"dd413a71-4f05-4f29-857d-0a075840ada8:LONG","positionKind":"LONG","marketValueUsd":"3816894","longBookWeight":"0.00164316","sharesPrincipal":{"type":"SH","amount":"1069158"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"dd413a71-4f05-4f29-857d-0a075840ada8","cusip":"359616109","issuerName":"FULCRUM THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"ea2c57e5-967e-4deb-b85d-6e0bebe4cf7f","positionKey":"1eba9ff0-296d-40e1-a2e1-40731ff19dc0:LONG","positionKind":"LONG","marketValueUsd":"3020063","longBookWeight":"0.00130013","sharesPrincipal":{"type":"SH","amount":"623980"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"1eba9ff0-296d-40e1-a2e1-40731ff19dc0","cusip":"92539P101","issuerName":"VERVE THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"fe53cb19-c64d-4cde-92a8-690da68e34cb","positionKey":"6ccc2c00-a218-4022-8222-7345d1318f71:LONG","positionKind":"LONG","marketValueUsd":"2046344","longBookWeight":"0.00088094","sharesPrincipal":{"type":"SH","amount":"217928"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-85.1406","valueChangePercent":"-82.6023","shareChangeAbsolute":"-1248682","valueChangeAbsolute":"-9715868"},"security":{"id":"6ccc2c00-a218-4022-8222-7345d1318f71","cusip":"462260100","issuerName":"IOVANCE BIOTHERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"0ca1e41a-f327-4547-85da-4391e163e70c","positionKey":"1de6929f-c603-4754-9487-48567a2998a0:LONG","positionKind":"LONG","marketValueUsd":"1872640","longBookWeight":"0.00080616","sharesPrincipal":{"type":"SH","amount":"1064000"},"comparison":{"status":"NEWLY_REPORTED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b"},"security":{"id":"1de6929f-c603-4754-9487-48567a2998a0","cusip":"43157M102","issuerName":"HILLEVAX INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"97d10e7e-1f25-498b-ab73-50d0ebf07129","positionKey":"d98547b8-0338-42a1-891e-ce67334164b7:LONG","positionKind":"LONG","marketValueUsd":"1258487","longBookWeight":"0.00054177","sharesPrincipal":{"type":"SH","amount":"801584"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-90.3364","valueChangePercent":"-90.9692","shareChangeAbsolute":"-7493366","valueChangeAbsolute":"-12677029"},"security":{"id":"d98547b8-0338-42a1-891e-ce67334164b7","cusip":"528872302","issuerName":"LEXICON PHARMACEUTICALS INC","classTitle":"COM NEW","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"dd6eec4b-2148-4925-bc60-f7909db53d44","positionKey":"b5e84ef8-d0b1-4974-85f2-58afee9bb928:LONG","positionKind":"LONG","marketValueUsd":"1141379","longBookWeight":"0.00049136","sharesPrincipal":{"type":"SH","amount":"1630542"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-33.243","valueChangePercent":"-41.6605","shareChangeAbsolute":"-811962","valueChangeAbsolute":"-815067"},"security":{"id":"b5e84ef8-d0b1-4974-85f2-58afee9bb928","cusip":"23306J200","issuerName":"DBV TECHNOLOGIES S A","classTitle":"SPONSORED ADR","securityType":"ADR","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"f61748c7-2a3a-4bf8-93db-4b5926e0c49c","positionKey":"fbc3d6de-9d6d-41b4-85ad-1cdbd8077bb2:LONG","positionKind":"LONG","marketValueUsd":"284054","longBookWeight":"0.00012228","sharesPrincipal":{"type":"SH","amount":"473503"},"comparison":{"status":"REDUCED","priorSnapshotId":"ee2b26ec-0136-4470-ab9a-0059aebb488b","shareChangePercent":"-80.8887","valueChangePercent":"-95.7537","shareChangeAbsolute":"-2004111","valueChangeAbsolute":"-6405504"},"security":{"id":"fbc3d6de-9d6d-41b4-85ad-1cdbd8077bb2","cusip":"28623U101","issuerName":"ELEVATION ONCOLOGY INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null}]}}